Skip to main content

Table 3 The serial change in mean value (SD) of IPSS and OABSS

From: Use of alpha-1 adrenoceptor antagonists in patients who underwent low-dose-rate brachytherapy for prostate cancer - a randomized controlled trial of silodosin versus naftopidil -

Variable

Baseline

1 month

3 months

6 months

12 months

IPSS (total)

Naftopidil (n=70)

6.8 (4.3)

15.5** (8.0)

17.4** (8.5)

13.5** (7.9)

9.8** (7.1)

Silodosin (n=71)

7.9 (5.5)

15.5** (9.5)

18.3** (9.1)

14.4** (7.9)

9.8** (7.2)

Total (n=141)

7.4 (5.0)

15.5** (8.7)

17.8** (8.8)

13.9** (7.9)

9.8** (7.1)

OABSS (total)

Naftopidil (n=70)

3.5 (2.2)

6.1** (3.4)

6.8** (3.8)

5.8** (3.2)

4.5** (3.0)

Silodosin (n=71)

3.4 (2.6)

6.2** (3.7)

6.4** (3.5)

5.2** (3.2)

4.0** (3.0)

Total (n=141)

3.4 (2.4)

6.2** (3.6)

6.6** (3.6)

5.5** (3.2)

4.3** (3.0)

  1. Baseline vs. *p < 0.05, **p < 0.01.